IL18 and small cell lung carcinoma: Having observed a marked improvement in the efficacy of our murine DLL3-targeting CAR T cells against systemic mSCLC in immunocompetent mice with CAR T cells secreting mIL-18, we sought to test the potential benefit of IL-18 on human CAR T cells in xenograft SCLC models.